Evi M. Mercken

5.9k total citations · 1 hit paper
26 papers, 3.0k citations indexed

About

Evi M. Mercken is a scholar working on Molecular Biology, Physiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Evi M. Mercken has authored 26 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Physiology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Evi M. Mercken's work include Genetics, Aging, and Longevity in Model Organisms (8 papers), Adipose Tissue and Metabolism (8 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (8 papers). Evi M. Mercken is often cited by papers focused on Genetics, Aging, and Longevity in Model Organisms (8 papers), Adipose Tissue and Metabolism (8 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (8 papers). Evi M. Mercken collaborates with scholars based in United States, Netherlands and Spain. Evi M. Mercken's co-authors include Rafael de Cabo, David Sinclair, Susan M. Krzysik-Walker, Nathan L. Price, Emiel F.�M. Wouters, Christiane D. Wrann, Javid J. Moslehi, Basil P. Hubbard, Ana P. Gomes and Nigel Turner and has published in prestigious journals such as Cell, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Evi M. Mercken

26 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Declining NAD+ Induces a Pseudohypoxic State Disrupting Nuclear-Mitochondrial Communication during Aging

2013 1.1k citations Ana P. Gomes, Nathan L. Price et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Evi M. Mercken United States	21	1.3k	1.2k	684	458	391	26	3.0k
Nazar Labinskyy United States	26	1.3k 1.0×	1.4k 1.2×	931 1.4×	325 0.7×	426 1.1×	40	3.7k
Nathan L. Price United States	26	1.5k 1.1×	908 0.8×	462 0.7×	313 0.7×	401 1.0×	47	3.0k
Wenjuan He United States	13	1.5k 1.2×	1.4k 1.2×	871 1.3×	122 0.3×	537 1.4×	23	3.2k
Yoshikazu Higami Japan	32	1.3k 1.0×	1.6k 1.3×	205 0.3×	718 1.6×	611 1.6×	160	3.5k
Thomas J. LaRocca United States	29	1.1k 0.9×	969 0.8×	137 0.2×	269 0.6×	383 1.0×	64	3.1k
Michael S. Bonkowski United States	26	949 0.7×	1.4k 1.2×	697 1.0×	730 1.6×	365 0.9×	45	2.8k
Hyunseok Kim South Korea	12	1.4k 1.1×	1.1k 0.9×	1.7k 2.4×	97 0.2×	897 2.3×	35	3.0k
Cuk‐Seong Kim South Korea	28	1.4k 1.1×	758 0.6×	528 0.8×	55 0.1×	426 1.1×	104	3.2k
Alexander Akhmedov Switzerland	28	1.2k 0.9×	663 0.6×	119 0.2×	130 0.3×	291 0.7×	75	2.6k
Kathryn F. Mills United States	10	1.2k 0.9×	1.3k 1.1×	1.9k 2.8×	243 0.5×	918 2.3×	11	3.9k

Countries citing papers authored by Evi M. Mercken

Since Specialization

Citations

This map shows the geographic impact of Evi M. Mercken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evi M. Mercken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evi M. Mercken more than expected).

Fields of papers citing papers by Evi M. Mercken

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evi M. Mercken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evi M. Mercken. The network helps show where Evi M. Mercken may publish in the future.

Co-authorship network of co-authors of Evi M. Mercken

This figure shows the co-authorship network connecting the top 25 collaborators of Evi M. Mercken. A scholar is included among the top collaborators of Evi M. Mercken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evi M. Mercken. Evi M. Mercken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tezze, Caterina, Leonardo Nogara, Martina Baraldo, et al.. (2023). A combination of metformin and galantamine exhibits synergistic benefits in the treatment of sarcopenia. JCI Insight. 8(15). 15 indexed citations

Pomatto, Laura C.D., Lindsey Carboneau, Sophia Levan, et al.. (2020). Deletion of Nrf2 shortens lifespan in C57BL6/J male mice but does not alter the health and survival benefits of caloric restriction. Free Radical Biology and Medicine. 152. 650–658. 25 indexed citations

Dirckx, Naomi, Robert J. Tower, Evi M. Mercken, et al.. (2018). Vhl deletion in osteoblasts boosts cellular glycolysis and improves global glucose metabolism. Journal of Clinical Investigation. 128(3). 1087–1105. 78 indexed citations

Reynaert, Niki L., Cheryl van de Wetering, Scott W. Aesif, et al.. (2017). Involvement of c-Jun N-Terminal Kinase in TNF-α–Driven Remodeling. American Journal of Respiratory Cell and Molecular Biology. 56(3). 393–401. 16 indexed citations

Mercken, Evi M., Miriam Capri, Lindsey Carboneau, et al.. (2017). Conserved and species-specific molecular denominators in mammalian skeletal muscle aging. SHILAP Revista de lepidopterología. 3(1). 8–8. 25 indexed citations

Reynaert, Niki L., Evi M. Mercken, Rafael de Cabo, et al.. (2015). Involvement of JNK in TNFα driven remodelling. PA5058–PA5058. 2 indexed citations

Mitchell, Eleanor, Alejandro Martín‐Montalvo, Evi M. Mercken, et al.. (2014). The SIRT1 Activator SRT1720 Extends Lifespan and Improves Health of Mice Fed a Standard Diet. Cell Reports. 6(5). 836–843. 313 indexed citations

Mercken, Evi M., Seth D. Crosby, Dudley W. Lamming, et al.. (2013). Calorie restriction in humans inhibits the PI3K/AKT pathway and induces a younger transcription profile. Aging Cell. 12(4). 645–651. 189 indexed citations

Mercken, Evi M., Jia Hu, Susan M. Krzysik-Walker, et al.. (2013). SIRT1 but not its increased expression is essential for lifespan extension in caloric‐restricted mice. Aging Cell. 13(1). 193–196. 86 indexed citations

10.

Gomes, Ana P., Nathan L. Price, Javid J. Moslehi, et al.. (2013). Declining NAD+ Induces a Pseudohypoxic State Disrupting Nuclear-Mitochondrial Communication during Aging. Cell. 155(7). 1624–1638. 1108 indexed citations breakdown →

11.

Lee, Eun Kyung, Wook Kim, Kumiko Tominaga, et al.. (2012). RNA-Binding Protein HuD Controls Insulin Translation. Molecular Cell. 45(6). 826–835. 84 indexed citations

12.

Mercken, Evi M., Lindsey Carboneau, Susan M. Krzysik-Walker, & Rafael de Cabo. (2011). Of mice and men: The benefits of caloric restriction, exercise, and mimetics. Ageing Research Reviews. 11(3). 390–398. 230 indexed citations

13.

Mercken, Evi M., et al.. (2010). Genetic Deletion of Nrf2 Promotes Immortalization and Decreases Life Span of Murine Embryonic Fibroblasts. The Journals of Gerontology Series A. 66A(3). 247–256. 29 indexed citations

14.

Mercken, Evi M., Geja J. Hageman, Ramon Langen, Emiel F.�M. Wouters, & Annemie M.W.J. Schols. (2010). Decreased Exercise-Induced Expression of Nuclear Factor-κB-Regulated Genes in Muscle of Patients With COPD. CHEST Journal. 139(2). 337–346. 23 indexed citations

15.

Abdelmohsen, Kotb, Mihee M. Kim, Subramanya Srikantan, et al.. (2010). miR-519 suppresses tumor growth by reducing HuR levels. Cell Cycle. 9(7). 1354–1359. 114 indexed citations

16.

Mercken, Evi M., et al.. (2009). Dichloroacetate Modulates the Oxidative Stress and Inflammatory Response to Exercise in COPD. CHEST Journal. 136(3). 744–751. 13 indexed citations

17.

Mercken, Evi M., Harry R. Gosker, Erica P.A. Rutten, et al.. (2009). Systemic and Pulmonary Oxidative Stress After Single-Leg Exercise in COPD. CHEST Journal. 136(5). 1291–1300. 28 indexed citations

18.

Dentener, Mieke A., Eva C. Creutzberg, William D‐C Man, et al.. (2008). Effect of Infliximab on Local and Systemic Inflammation in Chronic Obstructive Pulmonary Disease: A Pilot Study. Respiration. 76(3). 275–282. 58 indexed citations

19.

Houben, Joyce M.J., Evi M. Mercken, Hans B. Ketelslegers, et al.. (2008). Telomere shortening in chronic obstructive pulmonary disease. Respiratory Medicine. 103(2). 230–236. 96 indexed citations

20.

Mercken, Evi M., Geja J. Hageman, Annemie M.W.J. Schols, et al.. (2005). Rehabilitation Decreases Exercise-induced Oxidative Stress in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 172(8). 994–1001. 136 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact